DraftBlue Cross Blue Shield - TennesseePolicy N/A

Pneumatic and Non‑Pneumatic Limb Compression Pumps (Home Use) Coverage Criteria

Medical policy governing home use of pneumatic and non‑pneumatic compression pumps for lymphedema, DVT prophylaxis after major surgery, and other indications; applicable to Blue Cross Blue Shield - Tennessee members and providers who request coverage determinations.

Policy Summary

PayerBlue Cross Blue Shield - Tennessee

PolicyPneumatic and Non‑Pneumatic Limb Compression Pumps (Home Use) Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionObtain prior authorization when coverage depends on documented failure of conservative therapy, device type, or contraindication to anticoagulation.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

homesetting addressed

≤14dmax DVT prophylaxis

trunk/head/neckinvestigational devices

requiredFDA requirement

Coverage Criteria for Home Use Compression Pumps

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Medically appropriate uses (home setting)

Covered when ALL/ANY criteria below are met as specified:

Top-level allowed indications: Any one of the following indications qualifies as medically appropriate

Top-level grouping

Postoperative DVT prophylaxis (intermittent pneumatic device)

Duration: No longer than 14 days<= 14 days
Maximum postoperative home use duration
Device type: Intermittent pneumatic device
Device requirement
Contraindication to pharmacologic prophylaxis: Documented contraindication to pharmacological agents (examples: previous major bleeding, severe renal failure, concomitant antiplatelet agent, or surgical factors such as history of difficult-to-control surgical bleeding during current procedure, extensive surgical dissection, or revision surgery)
Clinical documentation required

Lymphedema — limb treatment: Treatment of lymphedema of one or more limbs is medically appropriate if criteria below for device type are met

See device-specific nodes

Nonprogrammable pump for intractable limb lymphedema: Nonprogrammable pump (single or multi-chamber) is appropriate for intractable lymphedema of one or more limbs when there is documented failure to respond to conservative measures (e.g., limb elevation, compression garments)

Documented failure required

Programmable pump for limb lymphedema

Conservative therapy failure: Documented failure to respond to conservative measures such as limb elevation and use of compression garments
Required
Additional documentation (ANY)
- Failure of initial nonprogrammable trial: Documented failure to respond to an initial trial of a nonprogrammable pump
  Step therapy requirement
- Characteristics preventing nonprogrammable performance: Documentation that the individual has characteristics that prevent satisfactory performance of nonprogrammable pneumatic compression (e.g., significant scarring, contractures, or recent surgery)
  Acceptable justification

Non-pneumatic wearable programmable pumps

Anatomic application: Pump is applied to one or more limbs
Anatomic requirement
Lymphedema treatment documentation
- Conservative therapy failure: Documented failure to respond to conservative measures such as limb elevation and use of compression garments
  Required
- Characteristics preventing pneumatic performance: Documentation that the individual has characteristics that prevent satisfactory pneumatic compression performance from nonprogrammable pumps (e.g., significant scarring, contractures, or recent surgery)
  Acceptable justification
- Failure of initial nonprogrammable trial:

The policy specifies that the use of pneumatic compression pumps in the home setting is considered medically necessary only when the documented medical appropriateness criteria are met. However, the policy explicitly designates the use of pneumatic compression pumps applied to the chest, trunk, head, or neck in the home for treatment of lymphedema (with or without limb involvement) as investigational. Providers should note that these anatomic applications are not covered under the home-use criteria and are at risk for denial when submitted for coverage.

In addition to head/neck/trunk/chest devices, the policy identifies other specific investigational uses. Home use of pneumatic or non‑pneumatic compression pumps for the treatment of venous ulcers is considered investigational due to insufficient evidence. The policy’s supplemental information reiterates that published evidence is inadequate in quality and quantity to support home use of compression devices for head and neck lymphedema or for venous ulcer treatment; such requests should therefore be considered not medically necessary or subject to denial.

Coding and Duration Limits

Document title/referencemixed

No codes listed

Maximum postoperative home use duration for DVT prophylaxis

Maximum postoperative home use duration for DVT prophylaxisNo longer than 14 days

Provider Requirements, Prior Authorization, and Denial Risks

Prior Authorization

Prior Authorization Required

Prior authorization is required when coverage is contingent on meeting the medical appropriateness criteria for pneumatic or non-pneumatic compression pumps. Providers should obtain authorization before device provision to avoid claim denials.

Applies when pump use is for DVT prophylaxis after major surgery or for lymphedema treatment meeting documented criteria.
Devices lacking FDA approval for the specific indication are investigational and at high risk for denial; prior authorization will not substitute for required FDA indication.

Step Therapy

Step Therapy Requirements

Step therapy must be documented and followed where specified: conservative measures first, then nonprogrammable pumps prior to programmable or wearable programmable devices unless an exception is documented.

Conservative measures include limb elevation and compression garments.
A documented trial of a nonprogrammable pump is required before coverage of a programmable pump unless there is documentation the member has characteristics that prevent satisfactory performance (e.g., significant scarring, contractures, or recent surgery).
For non‑pneumatic wearable programmable pumps, documentation must show failure of conservative measures and either failure of a nonprogrammable pump or characteristics that preclude nonprogrammable use, or lifestyle/mobility considerations affecting compliance with traditional systems.

Documentation Required

Required Clinical Documentation

Submit complete clinical documentation demonstrating failure or contraindication of prior conservative therapies and justification for the requested device type.

Documented failure to respond to conservative measures (e.g., limb elevation, compression garments) is required for lymphedema device requests.
If requesting a programmable pump, include documentation of an initial trial and failure of a nonprogrammable pump unless an exception is documented.
For wearable programmable devices, include documentation of lifestyle or mobility needs that prevent use of traditional systems, if applicable.
Clinical records should include dates, prior treatments tried, response to those treatments, relevant surgical history, and physical findings supporting device selection.

Documentation Required

DVT Prophylaxis Documentation

For DVT prophylaxis in the home after major surgery, documentation must show the postoperative context and a contraindication to pharmacologic prophylaxis.

DVT prophylaxis coverage is limited to intermittent pneumatic devices for no longer than 14 days in the home following major surgery (examples: total hip or knee arthroplasty, hip fracture surgery, open abdominal or pelvic procedures).
Include clear documentation of a contraindication to pharmacologic agents (e.g., prior major bleeding, severe renal failure, concomitant antiplatelet therapy, or surgical factors such as difficult-to-control bleeding, extensive dissection, or revision surgery).
Specify surgical procedure, date, indication for mechanical prophylaxis, and duration requested (≤14 days).

Denial Risk

Lack of FDA Indication — Denial Risk

Devices without FDA approval for the requested indication are investigational and may be denied.

Any device used must have FDA approval specific to the indication; absence of such approval = investigational/not covered.
Examples of investigational uses at higher risk of denial include chest/trunk/head/neck home pumps for lymphedema and compression pumps for venous ulcers, which lack sufficient published evidence and/or FDA indication.

Background

Pneumatic compression pumps (also called limb compression devices) apply intermittent or continuous pressure to body parts to assist lymphatic drainage, reduce edema, promote venous return, and can be used for postoperative deep vein thrombosis prophylaxis. The policy notes variation among devices in chamber configuration and function (for example, single versus multi‑chamber designs and programmable versus nonprogrammable operation). It also emphasizes that the evidence base for certain anatomic applications and for treatment of venous ulcers is limited, which is why chest/trunk/head/neck home applications and venous‑ulcer therapy are designated investigational.

Definitions

Nonprogrammable pump

DefinitionA pump that delivers fixed uniform pressure in each compartment and is not programmable for differing pressure cycles.

Configuration examplesSingle-chamber (nonsegmented / uniform pressure) or multi-chamber when not user-programmable.

Typical useUsed as initial therapy for intractable limb lymphedema after failure of conservative measures.

Programmable pump

DefinitionA pump where pressure is manually adjustable per compartment or programmable with varying designs allowing sequential inflation patterns.

FunctionalityMay permit manual adjustment of compartment pressures or programmable sequential inflation cycles to optimize therapy.

Clinical roleAppropriate when conservative measures have failed and after trial of a nonprogrammable pump or when nonprogrammable performance is unsatisfactory.

Non-pneumatic compression device

DefinitionA device that applies controlled pressure using mechanical, elastic, or spring-based systems rather than air (example: Dayspring).

Example deviceDayspring by Koya Medical, Inc.

Wearable programmable variantNon-pneumatic wearable programmable pumps may be appropriate when conservative measures fail or nonprogrammable trial fails and when lifestyle/mobility needs affect compliance.

Policy Summary

PayerBlue Cross Blue Shield - Tennessee

PolicyPneumatic and Non‑Pneumatic Limb Compression Pumps (Home Use) Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionObtain prior authorization when coverage depends on documented failure of conservative therapy, device type, or contraindication to anticoagulation.

SourceLink

On This Page

Documented failure to respond to an initial trial of a nonprogrammable pump

Step therapy alternative

Lifestyle or mobility justification: Documentation that the individual has lifestyle considerations or mobility requirements that affect compliance with traditional programmable pneumatic compression systems

Required for wearable programmable pumps